Targeting AKT with the proapoptotic peptide, TAT-CTMP: a novel strategy for the treatment of human pancreatic adenocarcinoma.

Targeting AKT with the proapoptotic peptide, TAT-CTMP: a novel strategy for the treatment of human pancreatic adenocarcinoma.

Item
http://www.wikidata.org/entity/Q30539569
HER3 as biomarker and therapeutic target in pancreatic cancer: new insights in pertuzumab therapy in preclinical modelsUse of multifunctional sigma-2 receptor ligand conjugates to trigger cancer-selective cell death signalingThe Use of a Liposomal Formulation Incorporating an Antimicrobial Peptide from Tilapia as a New Adjuvant to Epirubicin in Human Squamous Cell Carcinoma and Pluripotent Testicular Embryonic Carcinoma CellsCarboxyl-Terminal Modulator Protein Positively Acts as an Oncogenic Driver in Head and Neck Squamous Cell Carcinoma via Regulating Akt phosphorylationChallenges of drug resistance in the management of pancreatic cancer.Pertuzumab in gastrointestinal cancer.Inhibition of AMPK-related kinase 5 (ARK5) enhances cisplatin cytotoxicity in non-small cell lung cancer cells through regulation of epithelial-mesenchymal transitionThe Evolution of the Sigma-2 (σ2) Receptor from Obscure Binding Site to Bona Fide Therapeutic Target.ARK5 is associated with the invasive and metastatic potential of human breast cancer cells.Irinotecan synergistically enhances the antiproliferative and proapoptotic effects of axitinib in vitro and improves its anticancer activity in vivo.LY294002 enhances inhibitory effect of gemcitabine on proliferation of human pancreatic carcinoma PANC-1 cells.ST6Gal-I sialyltransferase promotes chemoresistance in pancreatic ductal adenocarcinoma by abrogating gemcitabine-mediated DNA damage.ARK5 promotes invasion and migration in hepatocellular carcinoma cells by regulating epithelial-mesenchymal transition.Novel link of anti-apoptotic ATF3 with pro-apoptotic CTMP in the ischemic brain.Overexpression of ARK5 is associated with poor prognosis in hepatocellular carcinoma.
P2860

Targeting AKT with the proapoptotic peptide, TAT-CTMP: a novel strategy for the treatment of human pancreatic adenocarcinoma.

Item
http://www.wikidata.org/entity/Q30539569
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Targeting AKT with the proapop ...... man pancreatic adenocarcinoma.
@ast
Targeting AKT with the proapop ...... man pancreatic adenocarcinoma.
@en
type
label
Targeting AKT with the proapop ...... man pancreatic adenocarcinoma.
@ast
Targeting AKT with the proapop ...... man pancreatic adenocarcinoma.
@en
prefLabel
Targeting AKT with the proapop ...... man pancreatic adenocarcinoma.
@ast
Targeting AKT with the proapop ...... man pancreatic adenocarcinoma.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Targeting AKT with the proapop ...... uman pancreatic adenocarcinoma
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932